Advanced search
Publication Cover
Nordic Journal of Psychiatry Volume 56, 2002 - Issue 4
Submit an article Journal homepage
40
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Sleep in patients with treated Wilson's disease. A questionnaire study

Kamilla Portala Department of Neuroscience, Psychiatry, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
,
Kerstin Westermark Department of Internal Medicine, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
,
Lisa Ekselius Department of Neuroscience, Psychiatry, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
&
Jan-Erik Broman Department of Neuroscience, Psychiatry, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
Pages 291-297 | Published online: 12 Jul 2009

  • Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith LH JR, editor. Major Problems in Internal Medicine, Vol XXIII. Philadelphia: WB Saunders Co; 1984.
  • Bull PC, Thomas GR, Kommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting Ptype APTase similar to the Menkes gene. Nat Genet 1993:5:327-37.
  • Petrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH, Gilliam TC. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 19943:1647-56.
  • Gollan JL, Gollan TJ. Wilson's disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998;28(Suppl 1):2836.
  • Dening TR, Berries GE. Wilson's disease: clinical groups in 400 cases. Acta Neurol Scand 1989:80:527-34.
  • Dening TR, Berrios GB. Wilson's Disease: a prospective study of psychopathology in 31 cases. Br J Psychiatry 1989:155:20613.
  • Borjigin J, Payne AS, Deng J, Li X, Wang MM, Ovodenko B, Gitlin JD, Synder SH. A novel pineal night-specific ATPase encoded by the Wilson Disease gene. J Neurosci 1999; 19:101826.
  • Barkhatova VP, Larsky G, Markova E, Ivanova-Smolenskaya IA, Demina EG. Changes in concentration of catecholamines in striatum of patients with hepatolenticular degeneration. In: Czlonkowska A, Van den Haner CJA, editors. Proceeding of the Sth Symposium on Wilson's Disease. Delft: Technical University; 1995. p. 165-73.
  • Nyberg P, Gottfries C-G, Holmgren G, Persson S, Roos B-E, Winblad B. Advanced catecholaminergic disturbances in the brain in a case of Wilson's disease. Acta Neurol Scand 1982:65:71-5.
  • Kish S, Dozik S, Deck J, Shannak K, Hornykiewicz O. Brain adrenergic changes in a patient with Wilson's disease. J Neuropat Exp Neurol 1990;49:280.
  • Nijeholt JL, Korf J. Wilson's disease and monoamines. Arch Neuro 1978;35:617.
  • Snow BJ, Bhatt M, Martin WRW, Li D, Calne DB. The nitrpstriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. J Neurol Neurosurg Psychiatry 1991;54:12-7.
  • Jeon B, Kim JM, Jeong JM, Kim KM, Chang YS, Lee SD, et al. Dopamine transporter imaging with [123I]-P-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease. J Neurol Neurosurg Psychiatry 1998;65:60-4.
  • Oertel WH, Tatsch K, Schwartz J, Kraf E, Trenkwalder C, Scherer J, et al. Decrease of D2 receptors indicated by 123 I-Iodobenzamide single-photon emisson computed tomography relates to neurological deficit in treated Wilson's disease. Ann Neurol 1992:32:743-8.
  • Westermark K, Tedroff J, Thuomas KA, Hartvig P, Langstrom B, Andersson Y, et al. Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers. Mov Disord 1995:10:596-603.
  • Hawkins RA, Mazziotta JC, Phelps ME. Wilson's disease studied with FDG and positron emission tomography. Neurology 1987:37:1707-11.
  • Kirkham T, Kamin DF. Slow saccadic eye movements in Wilson's disease. J Nerv Ment Dis 1956:124:251-5.
  • Berardelli A, Inghilleri M, Priori A, Thompson PD, Fabri S, Fieschi C, Manfred! M. Involvement of corticospinal tract in Wilson's disease. Mov Disord 1999;5:334-7.
  • Chu NS. Sensory evoked potentials in Wilson's disease. Brain 1986:109:491-507.
  • Grimm G, Madl C, Katzenschlager R, Oder W, Ferenci P, Gangl A. Detailed evaluation of evoked potentials in Wilson's disease. Electroenceph clin Neurophysiol 1992;82:11924.
  • Janson C, Gislason T, Boman G, Hetta J, Roos BE. Sleep disturbance in patients with asthma. Respir Med 1990;84:3742.
  • Elmasry A, Lindberg E, Beme C, Janson C, Gislason T. Sleepdisordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001;249:153-61.
  • Gudbjornsson B, Broman J-E, Hetta J, Hällgren R. Sleep disturbances in patients with primary Sjögren's syndrome. B J Rheumatology 1993;32:1072-6.
  • Hultgren S, Broman J-E, Gudbjornsson B, Hetta J, Lindqvist U. Sleep disturbances in outpatients with ankylosing spondylitis, a questionnaire study with gender implications. Scand J Rheumatol 2000;29:365-9.
  • Edell-Gustafsson U. Sleep, psychological symptoms and quality of life in patients undergoing coronary artery bypass grafting. Thesis, Linköping University; 1999.
  • Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorder: meta-analysis. Arch Gen Psychiatry 1992:49:651-68.
  • Portala K, Westermark K, Knorring Lv, Ekselius L. Psychopathology in treated Wilson's disease determined by means of CPRS expert and self-ratings. Acta Psychiatr Scand 2000:101:104-9.
  • Firneisz G, Szalay F, Halasz P, Komoly S. Hypersomnia in Wilson's disease: an unusual symptom in an unusual case. Acta Neurol Scand 2000:101:286-8.
  • McCarley RW, Greene RW, Rainnie D, et al. Brain stem neuromodulation and REM sleep. Semin Neurose! 1995:7:341-54.
  • Waldenström E, Lagerkvist A, Dahlman T, Westermark K, Landegren U. Efficient detection of mutations in Wilson disease by manifold sequencing. Genomics 1996:37:303-9.
  • Hetta J, Mallon L, Bengtsson H, Smedje H, Beoman J-E. Polysomnographic versus questionnaire data on difficulties falling asleep and total night sleep (abstract). J Sleep Res 1998;7(Suppl 2):16.
  • Hetta J, Almqvist M, Agren H, Hambert G, Liljeberg B, Roos B-E. Prevalence of sleep disturbances and related symptoms in middle-aged Swedish population. In: WP Koella, E Ruther, H Schulz, editors. Sleep '84. Stuttgart: Gustav Fischer Verlag; 1985. p. 373-6.
  • Broman J-E, Lundh L-G, Hetta J. Insufficient sleep in the general population. Neurophisol Clin 1996:26:30-9.
  • April RS. Observations on Parkinsonian tremor in all-night sleep. Neurology (New York) 1966:16:720-4.
  • Bergonzi P, Chiurulla C, Cianchetti, et al. Clinical pharmacology as an approach to the study of biochemical sleep mechanisms: the action of 1-dopa. Confin Neurol 1974:36:5-22.
  • Reynolds CF, Hoch CC, Stack J, Campbell D. The nature and management of sleep/wake disturbance in Alzheimer's dementia. Psychopharmacol Bull 1988;24:43-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.